|
DE59010908D1
(de)
|
1989-09-12 |
2000-08-10 |
Hoffmann La Roche |
TNF-bindende Proteine
|
|
US5705364A
(en)
†
|
1995-06-06 |
1998-01-06 |
Genentech, Inc. |
Mammalian cell culture process
|
|
US6656466B1
(en)
*
|
1995-06-06 |
2003-12-02 |
Genetech, Inc. |
Human tumor necrosis factor—immunoglobulin(TNFR1-IgG1) chimera composition
|
|
JP4306813B2
(ja)
|
1995-09-19 |
2009-08-05 |
アスビオファーマ株式会社 |
動物細胞の新規培養方法
|
|
HRP970224A2
(en)
*
|
1996-05-08 |
1998-04-30 |
Hoffmann La Roche |
TREATMENT OF ASTHMA WITH TNFR-Ig
|
|
ATE309350T1
(de)
*
|
1997-12-03 |
2005-11-15 |
Roche Diagnostics Gmbh |
Verfahren zur herstellung von polypeptiden mit geeigneter glykosilierung
|
|
US6140445A
(en)
*
|
1998-04-17 |
2000-10-31 |
Crompton Corporation |
Silane functional oligomer
|
|
ES2255765T3
(es)
*
|
1998-05-29 |
2006-07-01 |
Genentech, Inc. |
Procedimiento de cultivo de celulas para la produccion de glicoproteinas.
|
|
US6528286B1
(en)
*
|
1998-05-29 |
2003-03-04 |
Genentech, Inc. |
Mammalian cell culture process for producing glycoproteins
|
|
TR200504220T2
(tr)
|
1998-12-17 |
2007-04-24 |
Biogen Idec Ma Inc. |
Aktif limfotoksin-beta reseptör imunoglobülin şimeAktif limfotoksin-beta reseptör imunoglobülin şimerik proteinlerinin yüksek düzey ifadesi ve saflaştrik proteinlerinin yüksek düzey ifadesi ve saflaştırılması için bir yöntem.ırılması için bir yöntem.
|
|
GB9828624D0
(en)
*
|
1998-12-23 |
1999-02-17 |
Glaxo Group Ltd |
Production of proteins
|
|
KR100475417B1
(ko)
*
|
1998-12-30 |
2005-07-18 |
씨제이 주식회사 |
시알산 함량이 높은 재조합 당단백질의 제조방법
|
|
US7294481B1
(en)
|
1999-01-05 |
2007-11-13 |
Immunex Corporation |
Method for producing recombinant proteins
|
|
ATE348173T1
(de)
|
1999-04-26 |
2007-01-15 |
Genentech Inc |
Zellenzuchtverfahren für glycoproteine
|
|
US6261805B1
(en)
*
|
1999-07-15 |
2001-07-17 |
Boyce Thompson Institute For Plant Research, Inc. |
Sialyiation of N-linked glycoproteins in the baculovirus expression vector system
|
|
KR100394474B1
(ko)
*
|
1999-12-18 |
2003-08-09 |
동아제약 주식회사 |
동물세포에서 재조합 당단백질의 연속식 대량생산 방법
|
|
ATE313554T1
(de)
*
|
2000-05-16 |
2006-01-15 |
Lipoxen Technologies Ltd |
Derivatisierung von proteinen in wässrigem lösungsmittel
|
|
EP1298217A4
(en)
*
|
2000-07-05 |
2004-09-08 |
Mitsubishi Pharma Corp |
Process for the production of a glycoprotein
|
|
US20030040095A1
(en)
*
|
2001-03-16 |
2003-02-27 |
Achille Arini |
Method for the production of pharmaceutically active recombinant proteins
|
|
WO2002101019A2
(en)
*
|
2001-06-13 |
2002-12-19 |
Genentech, Inc. |
Methods of culturing animal cells and polypeptide production in animal cells
|
|
WO2003083066A2
(en)
|
2002-03-27 |
2003-10-09 |
Immunex Corporation |
Methods for increasing polypeptide production
|
|
US20030190710A1
(en)
*
|
2002-03-28 |
2003-10-09 |
Devries Ruth L. |
Control of glycoforms in IgG
|
|
US6924124B1
(en)
*
|
2002-08-23 |
2005-08-02 |
Immunex Corporation |
Feeding strategies for cell culture
|
|
US6974681B1
(en)
|
2002-08-23 |
2005-12-13 |
Immunex Corporation |
Cell culture performance with vanadate
|
|
US7067279B1
(en)
|
2002-08-23 |
2006-06-27 |
Immunex Corporation |
Cell culture performance with betaine
|
|
ATE472556T1
(de)
*
|
2002-12-02 |
2010-07-15 |
Amgen Fremont Inc |
Gegen den tumor nekrose faktor gerichtete antikörper und deren verwendungen
|
|
AU2003300276B2
(en)
*
|
2002-12-23 |
2010-07-01 |
Bristol-Myers Squibb Company |
Mammalian cell culture processes for protein production
|
|
US7332303B2
(en)
*
|
2002-12-23 |
2008-02-19 |
Bristol-Myers Squibb Company |
Product quality enhancement in mammalian cell culture processes for protein production
|
|
AU2004234377A1
(en)
*
|
2003-04-25 |
2004-11-11 |
Immunex Corporation |
Inducers of recombinant protein expression
|
|
PL1959011T3
(pl)
|
2003-10-24 |
2012-07-31 |
Selexis Sa |
Wysokowydajny transfer genu i ekspresja w komórkach ssaczych przez procedurę wielokrotnej transfekcji sekwencji regionu przylegania do macierzy
|
|
AU2004309114A1
(en)
*
|
2003-12-23 |
2005-07-14 |
Laboratoires Serono Sa |
Process for the production of tumor necrosis factor-binding proteins
|
|
EP1709185A1
(en)
*
|
2003-12-31 |
2006-10-11 |
Samyang Genex Corporation |
Method for mass production of secondary metabolites in plant cell culture by treatment of an alkanoic acid or salt thereof
|
|
EP1725673A1
(en)
*
|
2004-02-13 |
2006-11-29 |
Glycotope Gmbh |
Sialytated glycoproteins-process conditions and an efficient method for their production
|
|
US7300773B2
(en)
*
|
2004-08-27 |
2007-11-27 |
Wyeth Research Ireland Limited |
Production of TNFR-Ig
|
|
TWI384069B
(zh)
*
|
2004-08-27 |
2013-02-01 |
Pfizer Ireland Pharmaceuticals |
多胜肽之製法
|
|
TWI374935B
(en)
*
|
2004-08-27 |
2012-10-21 |
Pfizer Ireland Pharmaceuticals |
Production of α-abeta
|
|
EP1888637A2
(en)
*
|
2005-05-19 |
2008-02-20 |
Amgen Inc. |
Compositions and methods for increasing the stability of antibodies
|
|
WO2006128764A2
(en)
*
|
2005-06-03 |
2006-12-07 |
Biovitrum Ab (Publ) |
Process for cultivating animal cells comprising the feeding of plant-derived peptones
|
|
KR100670105B1
(ko)
|
2005-06-29 |
2007-01-17 |
주식회사 셀트리온 |
콩가수분해물의 저분자량 분획을 이용하여 시알산 함량이증가된 에리스로포이에틴을 생산하는 방법 및 그에 의하여생산된 시알산 함량이 증가된 에리스로포이에틴
|
|
WO2008057634A2
(en)
*
|
2006-10-26 |
2008-05-15 |
The Rockefeller University |
Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
|
|
US8470318B2
(en)
|
2005-11-07 |
2013-06-25 |
The Rockefeller University |
Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
|
|
PL2253644T3
(pl)
|
2005-12-20 |
2014-04-30 |
Bristol Myers Squibb Co |
Kompozycje i sposoby wytwarzania kompozycji
|
|
AR058568A1
(es)
|
2005-12-20 |
2008-02-13 |
Bristol Myers Squibb Co |
Metodos para producir una composicion con moleculas ctla4-ig a partir de un medio de cultivo
|
|
US20070190057A1
(en)
|
2006-01-23 |
2007-08-16 |
Jian Wu |
Methods for modulating mannose content of recombinant proteins
|
|
EP2264061A1
(en)
*
|
2006-01-26 |
2010-12-22 |
Recopharma AB |
Compositions and methods for inhibiting viral adhesion
|
|
EP2815768A3
(en)
|
2006-04-05 |
2015-01-14 |
The Rockefeller University |
Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
|
|
KR101495549B1
(ko)
*
|
2006-07-13 |
2015-02-25 |
와이어쓰 엘엘씨 |
당단백질의 생산
|
|
MX353340B
(es)
|
2006-09-13 |
2018-01-09 |
Abbvie Inc |
Mejoras de cultivos celulares.
|
|
US8911964B2
(en)
|
2006-09-13 |
2014-12-16 |
Abbvie Inc. |
Fed-batch method of making human anti-TNF-alpha antibody
|
|
US20080145893A1
(en)
*
|
2006-09-17 |
2008-06-19 |
Excellegene Sa |
Method for producing a recombinant protein at high specific productivity, high batch yield and high volumetric yield by means of transient transfection
|
|
WO2008069244A1
(ja)
*
|
2006-12-05 |
2008-06-12 |
Kyowa Hakko Kogyo Co., Ltd. |
糖蛋白質組成物の製造方法
|
|
BRPI0810472A2
(pt)
*
|
2007-04-16 |
2014-11-11 |
Momenta Pharmaceuticals Inc |
Métodos relacionados à glicosilação da superfície celular
|
|
TW200902708A
(en)
|
2007-04-23 |
2009-01-16 |
Wyeth Corp |
Methods of protein production using anti-senescence compounds
|
|
US20090023186A1
(en)
*
|
2007-07-22 |
2009-01-22 |
Excellgene Sa |
Use of valproic acid for enhancing production of recombinant proteins in mammalian cells
|
|
EP2188371B1
(en)
*
|
2007-08-09 |
2017-12-20 |
Wyeth LLC |
Use of perfusion to enhance production of fed-batch cell culture in bioreactors
|
|
TWI395593B
(zh)
*
|
2008-03-06 |
2013-05-11 |
Halozyme Inc |
可活化的基質降解酵素之活體內暫時性控制
|
|
CA2717383C
(en)
|
2008-03-06 |
2017-01-03 |
Halozyme, Inc. |
Large-scale production of soluble hyaluronidase
|
|
WO2009126564A1
(en)
|
2008-04-07 |
2009-10-15 |
Bayer Healthcare Llc |
Methods of recombinant production of glycoproteins
|
|
EP2279410B1
(en)
|
2008-04-22 |
2015-11-11 |
The Rockefeller University |
Methods of identifying anti-inflammatory compounds
|
|
MX347112B
(es)
|
2008-09-15 |
2017-04-12 |
Genentech Inc |
Composiciones y metodos para regular osmolaridad celular.
|
|
TW201024318A
(en)
*
|
2008-10-20 |
2010-07-01 |
Abbott Lab |
Isolation and purification of antibodies using protein A affinity chromatography
|
|
SG195577A1
(en)
|
2008-10-20 |
2013-12-30 |
Abbott Lab |
Viral inactivation during purification of antibodies
|
|
EA036569B1
(ru)
|
2008-12-09 |
2020-11-24 |
Галозим, Инк. |
Способ получения полипептида гиалуронидазы ph20
|
|
US20110229451A2
(en)
*
|
2009-03-06 |
2011-09-22 |
Halozyme, Inc. |
Temperature sensitive mutants of matrix metalloproteases and uses thereof
|
|
US9540426B2
(en)
|
2009-10-06 |
2017-01-10 |
Bristol-Myers Squibb Company |
Mammalian cell culture processes for protein production
|
|
CN104928336B
(zh)
|
2009-10-26 |
2020-05-08 |
弗·哈夫曼-拉罗切有限公司 |
用于生产糖基化免疫球蛋白的方法
|
|
DK2501822T3
(da)
|
2009-11-17 |
2017-11-27 |
Squibb & Sons Llc |
Fremgangsmåder til forbedret proteinproduktion
|
|
CN102770458A
(zh)
*
|
2009-12-02 |
2012-11-07 |
阿塞勒隆制药公司 |
用于增加Fc融合蛋白的血清半寿期的组合物和方法
|
|
NZ601790A
(en)
*
|
2010-02-24 |
2014-03-28 |
Zymenex As |
Process for production and purification of recombinant lysosomal alpha-mannosidase
|
|
WO2012017925A1
(ja)
|
2010-08-02 |
2012-02-09 |
協和発酵キリン株式会社 |
物質の製造方法
|
|
WO2012122625A1
(en)
|
2011-03-14 |
2012-09-20 |
National Research Council Of Canada |
Method of viral production in cells
|
|
US9062106B2
(en)
|
2011-04-27 |
2015-06-23 |
Abbvie Inc. |
Methods for controlling the galactosylation profile of recombinantly-expressed proteins
|
|
KR101591671B1
(ko)
|
2011-04-29 |
2016-02-04 |
바이오콘 리서치 리미티드 |
항체의 이질성을 감소시키는 방법 및 그 항체의 제조방법
|
|
EP2718328A4
(en)
|
2011-06-08 |
2014-12-24 |
Acceleron Pharma Inc |
COMPOSITIONS AND METHODS FOR INCREASING THE HALF TIME OF SERUM
|
|
WO2013158273A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Methods to modulate c-terminal lysine variant distribution
|
|
US9067990B2
(en)
|
2013-03-14 |
2015-06-30 |
Abbvie, Inc. |
Protein purification using displacement chromatography
|
|
WO2013158279A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Protein purification methods to reduce acidic species
|
|
US9249182B2
(en)
|
2012-05-24 |
2016-02-02 |
Abbvie, Inc. |
Purification of antibodies using hydrophobic interaction chromatography
|
|
CN102839157A
(zh)
*
|
2012-07-12 |
2012-12-26 |
扬州大学 |
稳定共表达hST3GalIV和β1-4GalT1的MDCK细胞系及构建方法和应用
|
|
US9512214B2
(en)
|
2012-09-02 |
2016-12-06 |
Abbvie, Inc. |
Methods to control protein heterogeneity
|
|
KR20150043523A
(ko)
|
2012-09-02 |
2015-04-22 |
애브비 인코포레이티드 |
단백질 불균일성의 제어 방법
|
|
NO2760138T3
(2)
|
2012-10-01 |
2018-08-04 |
|
|
|
JP2015531244A
(ja)
|
2012-10-15 |
2015-11-02 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
タンパク質を製造するための哺乳動物細胞培養方法
|
|
US20140106405A1
(en)
*
|
2012-10-15 |
2014-04-17 |
Bristol-Myers Squibb Company |
Mammalian cell culture processes for protein production
|
|
SG11201507230PA
(en)
|
2013-03-12 |
2015-10-29 |
Abbvie Inc |
Human antibodies that bind human tnf-alpha and methods of preparing the same
|
|
US9217168B2
(en)
|
2013-03-14 |
2015-12-22 |
Momenta Pharmaceuticals, Inc. |
Methods of cell culture
|
|
US9017687B1
(en)
|
2013-10-18 |
2015-04-28 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same using displacement chromatography
|
|
US8921526B2
(en)
|
2013-03-14 |
2014-12-30 |
Abbvie, Inc. |
Mutated anti-TNFα antibodies and methods of their use
|
|
WO2014151878A2
(en)
|
2013-03-14 |
2014-09-25 |
Abbvie Inc. |
Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
|
|
AR095196A1
(es)
|
2013-03-15 |
2015-09-30 |
Regeneron Pharma |
Medio de cultivo celular libre de suero
|
|
BR112015032960B1
(pt)
|
2013-07-04 |
2021-01-05 |
F. Hoffmann-La Roche Ag |
imunoensaio suprimido por interferência para detectar anticorpos anti-fármaco em amostras de soro
|
|
HK1218297A1
(zh)
|
2013-07-06 |
2017-02-10 |
Cadila Healthcare Limited |
用於生产单克隆抗体的改进方法
|
|
EP3052640A2
(en)
|
2013-10-04 |
2016-08-10 |
AbbVie Inc. |
Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
|
|
US9085618B2
(en)
|
2013-10-18 |
2015-07-21 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same
|
|
US9181337B2
(en)
|
2013-10-18 |
2015-11-10 |
Abbvie, Inc. |
Modulated lysine variant species compositions and methods for producing and using the same
|
|
US8946395B1
(en)
|
2013-10-18 |
2015-02-03 |
Abbvie Inc. |
Purification of proteins using hydrophobic interaction chromatography
|
|
WO2015073884A2
(en)
|
2013-11-15 |
2015-05-21 |
Abbvie, Inc. |
Glycoengineered binding protein compositions
|
|
WO2015128314A1
(en)
*
|
2014-02-27 |
2015-09-03 |
F. Hoffmann-La Roche Ag |
Modulation of cell growth and glycosylation in recombinant glycoprotein production
|
|
JP6652334B2
(ja)
|
2014-05-31 |
2020-02-19 |
Ｊｃｒファーマ株式会社 |
ウリジンとｎ−アセチル−ｄ−マンノサミンとを含有する培地
|
|
MX2016015971A
(es)
*
|
2014-06-03 |
2017-08-08 |
Lupin Ltd |
Proceso de cultivo celular para la producción de una proteína.
|
|
US20160130324A1
(en)
|
2014-10-31 |
2016-05-12 |
Shire Human Genetic Therapies, Inc. |
C1 Inhibitor Fusion Proteins and Uses Thereof
|
|
KR102007930B1
(ko)
*
|
2014-12-31 |
2019-08-06 |
주식회사 엘지화학 |
재조합 당단백질의 글리코실화 조절 방법
|
|
TWI870789B
(zh)
|
2015-08-04 |
2025-01-21 |
美商再生元醫藥公司 |
補充牛磺酸之細胞培養基及用法
|
|
WO2017087882A1
(en)
|
2015-11-19 |
2017-05-26 |
Shire Human Genetic Therapies, Inc. |
Recombinant human c1 esterase inhibitor and uses thereof
|
|
BR112018013501B1
(pt)
*
|
2015-12-29 |
2022-12-20 |
N.V. Nutricia |
Uso de um ingrediente fermentado e oligossacarídeo não digerível
|
|
JP7471220B2
(ja)
*
|
2017-11-30 |
2024-04-19 |
エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト |
哺乳動物細胞の培養方法
|
|
AU2019379858B2
(en)
|
2018-11-13 |
2024-01-04 |
Janssen Biotech, Inc. |
Control of trace metals during production of anti-CD38 antibodies
|
|
US12297451B1
(en)
|
2019-10-25 |
2025-05-13 |
Regeneron Pharmaceuticals, Inc. |
Cell culture medium
|
|
KR20240007293A
(ko)
|
2019-12-06 |
2024-01-16 |
리제너론 파아마슈티컬스, 인크. |
항-vegf 단백질 조성물 및 이를 생산하는 방법
|
|
MX2022013812A
(es)
|
2020-05-08 |
2022-12-15 |
Regeneron Pharma |
Trampas y mini-trampas de vegf y metodos para el tratamiento de trastornos oculares y cancer.
|
|
IL300828A
(en)
|
2020-08-31 |
2023-04-01 |
Regeneron Pharma |
Asparagine feeding strategies to improve cell culture performance and reduce asparagine sequence variants
|
|
TW202233827A
(zh)
|
2021-01-20 |
2022-09-01 |
美商再生元醫藥公司 |
改良細胞培養中蛋白質效價的方法
|
|
JP2024538673A
(ja)
|
2021-10-07 |
2024-10-23 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
ｐＨモデリング及び制御のシステム及び方法
|
|
KR20240090312A
(ko)
|
2021-10-07 |
2024-06-21 |
리제너론 파아마슈티컬스, 인크. |
Ph 미터 보정 및 교정
|
|
JP2025507790A
(ja)
|
2022-03-02 |
2025-03-21 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
高力価抗体のための製造プロセス
|
|
WO2025219232A1
(en)
|
2024-04-15 |
2025-10-23 |
Evonik Operations Gmbh |
Application of small peptides supplemented cell culture media for improved cell performance
|